Subsidiary19 May 2026, 06:21 pm
Acutaas Chemicals: ACEPL Status Changes to Subsidiary
AI Summary
Acutaas Chemicals Ltd announces that Acutaas Chemicals Electrolytes Private Limited (ACEPL) is no longer a wholly-owned subsidiary, effective May 19, 2026. This follows the allotment of 1,111 equity shares to A.R.Z Pharma Ltd, reducing Acutaas Chemicals' stake in ACEPL from 100% to 90%. The dilution does not affect management control, with ACEPL remaining under Acutaas Chemicals' management. The equity shares were issued at ₹52,490 per share, including a premium of ₹52,480.
Key Highlights
- ACEPL ceases to be a wholly-owned subsidiary of Acutaas Chemicals, now a subsidiary.
- Acutaas Chemicals' shareholding in ACEPL reduced from 100% to 90%.
- 1,111 equity shares allotted to A.R.Z Pharma Ltd at ₹52,490 per share.
- Management control of ACEPL remains with Acutaas Chemicals Ltd.
- The number of equity shares held by the Company in ACEPL remains unchanged.
Price Impact
More from AMIORG